Doxorubicin Exposure Causes Subacute Cardiac Atrophy Dependent on the Striated Muscle–Specific Ubiquitin Ligase MuRF1
出版年份 2019 全文链接
标题
Doxorubicin Exposure Causes Subacute Cardiac Atrophy Dependent on the Striated Muscle–Specific Ubiquitin Ligase MuRF1
作者
关键词
-
出版物
Circulation-Heart Failure
Volume 12, Issue 3, Pages -
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2019-03-15
DOI
10.1161/circheartfailure.118.005234
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Left Ventricular Mass Change After Anthracycline Chemotherapy
- (2018) Jennifer H. Jordan et al. Circulation-Heart Failure
- Anthracycline-induced cardiotoxicity: A multicenter randomised trial comparing two strategies for guiding prevention with enalapril: The International CardioOncology Society-one trial
- (2018) Daniela Cardinale et al. EUROPEAN JOURNAL OF CANCER
- Carvedilol for Prevention of Chemotherapy-Related Cardiotoxicity
- (2018) Mônica Samuel Avila et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The factor Xa inhibitor rivaroxaban reduces cardiac dysfunction in a mouse model of myocardial infarction
- (2018) Michael F. Bode et al. THROMBOSIS RESEARCH
- Anthracycline Therapy Is Associated With Cardiomyocyte Atrophy and Preclinical Manifestations of Heart Disease
- (2018) Thiago Ferreira de Souza et al. JACC-Cardiovascular Imaging
- Small-molecule inhibition of MuRF1 attenuates skeletal muscle atrophy and dysfunction in cardiac cachexia
- (2017) Thomas Scott Bowen et al. Journal of Cachexia Sarcopenia and Muscle
- Control of skeletal muscle atrophy in response to disuse: clinical/preclinical contentions and fallacies of evidence
- (2016) Philip J. Atherton et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- The pathogenesis and treatment of cardiac atrophy in cancer cachexia
- (2016) Kate T. Murphy AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Cancer Therapy–Related Cardiac Dysfunction and Heart Failure
- (2016) Michelle W. Bloom et al. Circulation-Heart Failure
- Prognostic value of sarcopenia in adults with solid tumours: A meta-analysis and systematic review
- (2016) Shlomit Strulov Shachar et al. EUROPEAN JOURNAL OF CANCER
- Heart Failure Therapies for End-Stage Chemotherapy–Induced Cardiomyopathy
- (2016) Roy B. Mukku et al. JOURNAL OF CARDIAC FAILURE
- Doxorubicin-induced chronic dilated cardiomyopathy—the apoptosis hypothesis revisited
- (2016) Cynthia Kankeu et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- VEGF-B gene therapy inhibits doxorubicin-induced cardiotoxicity by endothelial protection
- (2016) Markus Räsänen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Sarcopenia is an independent prognostic factor in male patients with diffuse large B-cell lymphoma
- (2015) Nobuhiko Nakamura et al. ANNALS OF HEMATOLOGY
- Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
- (2015) D. Cardinale et al. CIRCULATION
- Cardiovascular biomarkers in patients with cancer and their association with all-cause mortality
- (2015) Noemi Pavo et al. HEART
- Increased mitochondrial emission of reactive oxygen species and calpain activation are required for doxorubicin-induced cardiac and skeletal muscle myopathy
- (2015) Kisuk Min et al. JOURNAL OF PHYSIOLOGY-LONDON
- Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1
- (2014) Sue C. Bodine et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Effects of short-term endurance exercise training on acute doxorubicin-induced FoxO transcription in cardiac and skeletal muscle
- (2014) Andreas N. Kavazis et al. JOURNAL OF APPLIED PHYSIOLOGY
- Over-expression of calpastatin aggravates cardiotoxicity induced by doxorubicin
- (2013) Yanpeng Wang et al. CARDIOVASCULAR RESEARCH
- Role of the Ubiquitin Proteasome System in the Heart
- (2013) Julia Pagan et al. CIRCULATION RESEARCH
- The role of ubiquitin ligases in cardiac disease
- (2013) Monte S. Willis et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Pharmacogenomics as a risk mitigation strategy for chemotherapeutic cardiotoxicity
- (2013) Brian C Jensen et al. PHARMACOGENOMICS
- Low to Moderate Dose Anthracycline-Based Chemotherapy Is Associated With Early Noninvasive Imaging Evidence of Subclinical Cardiovascular Disease
- (2013) Brandon C. Drafts et al. JACC-Cardiovascular Imaging
- Mechanical Unloading Activates FoxO3 to Trigger Bnip3‐Dependent Cardiomyocyte Atrophy
- (2013) Dian J. Cao et al. Journal of the American Heart Association
- Left Ventricular Mass in Patients With a Cardiomyopathy After Treatment With Anthracyclines
- (2012) Tomas G. Neilan et al. AMERICAN JOURNAL OF CARDIOLOGY
- Daunorubicin therapy is associated with upregulation of E3 ubiquitin ligases in the heart
- (2012) Balindiwe J N Sishi et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies
- (2012) Yanti Octavia et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Identification of the molecular basis of doxorubicin-induced cardiotoxicity
- (2012) Sui Zhang et al. NATURE MEDICINE
- Elevated Myocardial Enzymes and Natriuretic Peptides in Anorexia Nervosa: Prototypic Condition for the Pathophysiology of Cachexia?
- (2011) Arne Zastrow et al. CARDIOLOGY
- Taking pressure off the heart: the ins and outs of atrophic remodelling
- (2011) K. K. Baskin et al. CARDIOVASCULAR RESEARCH
- Calpain-mediated dystrophin disruption may be a potential structural culprit behind chronic doxorubicin-induced cardiomyopathy
- (2011) Erica C. Campos et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Muscle ring finger 1 mediates cardiac atrophy in vivo
- (2009) Monte S. Willis et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Nonpegylated liposomal doxorubicin (MyocetTM) combination (R-COMP) chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL): results from the phase II EUR018 trial
- (2009) S. Luminari et al. ANNALS OF ONCOLOGY
- Atrogin-1 and MuRF1 regulate cardiac MyBP-C levels via different mechanisms
- (2009) Giulia Mearini et al. CARDIOVASCULAR RESEARCH
- Atrogin-1 ubiquitin ligase is upregulated by doxorubicin via p38-MAP kinase in cardiac myocytes
- (2008) Yasuhiro Yamamoto et al. CARDIOVASCULAR RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started